Trial in Progress: A Phase I/II Study of Lintuzumab-Ac225 in Older Patients with Untreated Acute Myeloid Leukemia
Year: 2017
Type: article
Authors: Joseph G. Jurcic, Moshe Levy, Jae Park, Farhad Ravandi, Alexander Perl, John Pagel, B. Douglas Smith, Johnnie Orozco, Elihu Estey, Hagop Kantarjian, David Scheinberg, Laura Finn, Sharif Khan, Gerhard Hildebrandt, Michael Craig, Ehab Atallah, Irma Molina, Dragan Cicic, Gregory Bergonio, Mark Berger
Institutions: Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, Columbia University, Baylor University Medical Center, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of Pennsylvania, Swedish Medical Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Washington, Fred Hutch Cancer Center, Ochsner Medical Center, University of Kentucky, Markey Cancer Center, West Virginia University, Medical College of Wisconsin Cancer Center, VA Caribbean Healthcare System, Actinium Pharmaceuticals (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2752456039